Cansino Biologics Stock Buy Hold or Sell Recommendation

CASBF Stock  USD 3.90  0.00  0.00%   
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding CanSino Biologics is 'Cautious Hold'. Macroaxis provides CanSino Biologics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CASBF positions.
  
Check out CanSino Biologics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as CanSino and provide practical buy, sell, or hold advice based on investors' constraints. CanSino Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Execute CanSino Biologics Buy or Sell Advice

The CanSino recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on CanSino Biologics. Macroaxis does not own or have any residual interests in CanSino Biologics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute CanSino Biologics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell CanSino BiologicsBuy CanSino Biologics
Cautious Hold

Market Performance

GoodDetails

Volatility

Very riskyDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Moves totally opposite to the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon CanSino Biologics has a Mean Deviation of 2.82, Standard Deviation of 6.81 and Variance of 46.36
We provide trade advice to complement the prevailing expert consensus on CanSino Biologics. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure CanSino Biologics is not overpriced, please confirm all CanSino Biologics fundamentals, including its net income, book value per share, and the relationship between the revenue and total debt . Given that CanSino Biologics has a shares owned by institutions of 38.17 %, we suggest you to validate CanSino Biologics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

CanSino Biologics Trading Alerts and Improvement Suggestions

CanSino Biologics is way too risky over 90 days horizon
CanSino Biologics appears to be risky and price may revert if volatility continues
About 27.0% of the company shares are held by company insiders

CanSino Biologics Returns Distribution Density

The distribution of CanSino Biologics' historical returns is an attempt to chart the uncertainty of CanSino Biologics' future price movements. The chart of the probability distribution of CanSino Biologics daily returns describes the distribution of returns around its average expected value. We use CanSino Biologics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of CanSino Biologics returns is essential to provide solid investment advice for CanSino Biologics.
Mean Return
0.95
Value At Risk
0.00
Potential Upside
11.11
Standard Deviation
6.81
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of CanSino Biologics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

CanSino Biologics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CanSino Biologics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CanSino Biologics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CanSino pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
1.02
β
Beta against Dow Jones-0.99
σ
Overall volatility
6.56
Ir
Information ratio 0.12

CanSino Biologics Volatility Alert

CanSino Biologics is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure CanSino Biologics' pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact CanSino Biologics' pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

CanSino Biologics Fundamentals Vs Peers

Comparing CanSino Biologics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze CanSino Biologics' direct or indirect competition across all of the common fundamentals between CanSino Biologics and the related equities. This way, we can detect undervalued stocks with similar characteristics as CanSino Biologics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of CanSino Biologics' fundamental indicators could also be used in its relative valuation, which is a method of valuing CanSino Biologics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare CanSino Biologics to competition
FundamentalsCanSino BiologicsPeer Average
Return On Equity0.0111-0.31
Return On Asset-0.0207-0.14
Profit Margin0.06 %(1.27) %
Operating Margin(0.19) %(5.51) %
Current Valuation3.58 B16.62 B
Shares Outstanding114.78 M571.82 M
Shares Owned By Insiders26.70 %10.09 %
Shares Owned By Institutions38.17 %39.21 %
Price To Earning19.25 X28.72 X
Price To Book2.30 X9.51 X
Price To Sales2.51 X11.42 X
Revenue4.3 B9.43 B
Gross Profit3 B27.38 B
EBITDA2.05 B3.9 B
Net Income1.91 B570.98 M
Cash And Equivalents7 B2.7 B
Cash Per Share28.36 X5.01 X
Total Debt40 M5.32 B
Debt To Equity0.26 %48.70 %
Current Ratio2.99 X2.16 X
Book Value Per Share29.22 X1.93 K
Cash Flow From Operations2.05 B971.22 M
Earnings Per Share0.59 X3.12 X
Number Of Employees1.95 K18.84 K
Beta0.61-0.15
Market Capitalization3.15 B19.03 B
Total Asset11.87 B29.47 B
Z Score46.88.72
Annual Yield0.01 %
Net Asset11.87 B
Last Dividend Paid0.8

CanSino Biologics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as CanSino . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About CanSino Biologics Buy or Sell Advice

When is the right time to buy or sell CanSino Biologics? Buying financial instruments such as CanSino Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having CanSino Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aggressive Funds Thematic Idea Now

Aggressive Funds
Aggressive Funds Theme
Funds or Etfs that attempt to achieve high capital gains by investing in companies with high growth potential and above average risk. The Aggressive Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in CanSino Pink Sheet

CanSino Biologics financial ratios help investors to determine whether CanSino Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CanSino with respect to the benefits of owning CanSino Biologics security.